REGENXBIO Inc 10-Q for FY2025 Q1
REGENXBIO Inc. (RGNX)
10-Q
2025-05-12
For: 2025-03-31
View Original
Added on
April 06, 2026
About this 10-Q
REGENXBIO Inc filed this 10-Q on May 12, 2025, covering the quarter ended March 31, 2025 (FY2025 Q1).
Headline figures
Quarter ended March 31, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $89.01M
- up 469.8% from $15.62M a year earlier
- Net income
- $6.08M
- compared with a net loss of $63.33M a year earlier
- Diluted EPS
- $0.12
- compared with -$1.38 a year earlier